MedicarePartD.guide

A non-government resource built from CMS public data

Pulmonary fibrosis drugs on SilverScript Choice (S5601-068)

Ofev and pirfenidone, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Alaska
Premium
$94.90/month
Deductible
$615.00
Change plan

2 of 3 Pulmonary fibrosis drugs are covered on this plan. All 2 require prior authorization.

1 isn't on the formulary (Esbriet).

  • Ofev
    nintedanib
    Covered · prior auth
    $3,631.10
    Tier 5
  • pirfenidone
    generic Esbriet
    Covered · prior auth
    from $1,662.97
    Tier 5
Not on the formulary
Esbriet

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list